Skip to main content
Journal cover image

How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ.

Publication ,  Journal Article
Record, SM; Hwang, E-SS; Chiba, A
Published in: Surg Oncol Clin N Am
October 2023

DCIS detection has increased dramatically since the introduction of screening mammography. Current guidance concordant care recommends surgical intervention for all patients with DCIS, followed by radiation and/or endocrine therapy for some. Adjuvant therapies after surgical excision have reduced recurrence rates but not breast cancer mortality. Given the lack of evidence of current treatment regimens and the morbidity associated with these treatments, there is concern that DCIS is over-treated. Active surveillance may be a favorable alternative for selected patients and is currently being investigated through four international clinical trials.

Duke Scholars

Published In

Surg Oncol Clin N Am

DOI

EISSN

1558-5042

Publication Date

October 2023

Volume

32

Issue

4

Start / End Page

663 / 673

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Mammography
  • Humans
  • Female
  • Early Detection of Cancer
  • Combined Modality Therapy
  • Carcinoma, Intraductal, Noninfiltrating
  • Breast Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Record, S. M., Hwang, E.-S., & Chiba, A. (2023). How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ. Surg Oncol Clin N Am, 32(4), 663–673. https://doi.org/10.1016/j.soc.2023.05.011
Record, Sydney M., Eun-Sil Shelley Hwang, and Akiko Chiba. “How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ.Surg Oncol Clin N Am 32, no. 4 (October 2023): 663–73. https://doi.org/10.1016/j.soc.2023.05.011.
Record SM, Hwang E-SS, Chiba A. How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ. Surg Oncol Clin N Am. 2023 Oct;32(4):663–73.
Record, Sydney M., et al. “How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ.Surg Oncol Clin N Am, vol. 32, no. 4, Oct. 2023, pp. 663–73. Pubmed, doi:10.1016/j.soc.2023.05.011.
Record SM, Hwang E-SS, Chiba A. How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ. Surg Oncol Clin N Am. 2023 Oct;32(4):663–673.
Journal cover image

Published In

Surg Oncol Clin N Am

DOI

EISSN

1558-5042

Publication Date

October 2023

Volume

32

Issue

4

Start / End Page

663 / 673

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Mammography
  • Humans
  • Female
  • Early Detection of Cancer
  • Combined Modality Therapy
  • Carcinoma, Intraductal, Noninfiltrating
  • Breast Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis